Uflex Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 21, 2025, 12:11 pm

Market Cap	4,251 Cr.
Current Price	589
High / Low	860/438
Stock P/E	18.7
Book Value	1,024
Dividend Yield	0.17 %
ROCE	7.51 %
ROE	3.11 %
Face Value	10.0
PEG Ratio	-0.62

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Uflex Ltd

Competitors of Uflex Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Hindustan Tin Works Ltd	177 Cr.	170	239/133	14.4	207	0.71 %	7.92 %	5.84 %	10.0
Gujarat Containers Ltd	94.4 Cr.	167	200/157	11.4	90.5	0.90 %	18.4 %	17.4 %	10.0
Goblin India Ltd	25.0 Cr.	18.1	46.0/17.0	12.9	31.2	0.00 %	7.73 %	4.64 %	10.0
G K P Printing & Packaging Ltd	13.3 Cr.	6.06	10.4/4.85	15.7	10.2	0.00 %	4.87 %	3.87 %	10.0
Garware Hi Tech Films Ltd	9,359 Cr.	4,028	5,378/1,945	28.3	1,021	0.25 %	20.5 %	15.0 %	10.0
Industry Average	2,441.38 Cr	366.83		58.42	181.03	0.29%	12.34%	18.47%	7.38

All Competitor Stocks of Uflex Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	3,868	4,032	3,768	3,483	3,380	3,258	3,369	3,309	3,426	3,654	3,833	3,735	3,814
Expenses	3,219	3,321	3,356	3,219	3,011	2,975	2,984	2,978	3,060	3,242	3,441	3,281	3,401
Operating Profit	649	711	412	264	370	284	386	332	366	412	392	454	413
OPM %	17%	18%	11%	8%	11%	9%	11%	10%	11%	11%	10%	12%	11%
Other Income	47	14	81	-70	-52	-362	20	-64	-319	-152	-73	65	129
Interest	98	105	105	133	130	135	132	140	128	162	178	174	184
Depreciation	140	144	146	144	166	160	164	166	165	173	173	172	176
Profit before tax	458	476	242	-83	22	-373	110	-39	-247	-76	-31	173	182
Tax %	23%	21%	21%	3%	96%	12%	42%	72%	10%	30%	108%	21%	7%
Net Profit	351	375	191	-85	1	-416	63	-67	-271	-98	-65	137	169
EPS in Rs	48.51	51.86	26.41	-11.83	0.12	-57.63	8.77	-9.31	-37.51	-13.63	-8.95	18.95	23.34

Last Updated: May 31, 2025, 7:26 am

Below is a detailed analysis of the quarterly data for Uflex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 3,814.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,735.00 Cr. (Dec 2024) to 3,814.00 Cr., marking an increase of 79.00 Cr..
For Expenses, as of Mar 2025, the value is 3,401.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,281.00 Cr. (Dec 2024) to 3,401.00 Cr., marking an increase of 120.00 Cr..
For Operating Profit, as of Mar 2025, the value is 413.00 Cr.. The value appears to be declining and may need further review. It has decreased from 454.00 Cr. (Dec 2024) to 413.00 Cr., marking a decrease of 41.00 Cr..
For OPM %, as of Mar 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Dec 2024) to 11.00%, marking a decrease of 1.00%.
For Other Income, as of Mar 2025, the value is 129.00 Cr.. The value appears strong and on an upward trend. It has increased from 65.00 Cr. (Dec 2024) to 129.00 Cr., marking an increase of 64.00 Cr..
For Interest, as of Mar 2025, the value is 184.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 174.00 Cr. (Dec 2024) to 184.00 Cr., marking an increase of 10.00 Cr..
For Depreciation, as of Mar 2025, the value is 176.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 172.00 Cr. (Dec 2024) to 176.00 Cr., marking an increase of 4.00 Cr..
For Profit before tax, as of Mar 2025, the value is 182.00 Cr.. The value appears strong and on an upward trend. It has increased from 173.00 Cr. (Dec 2024) to 182.00 Cr., marking an increase of 9.00 Cr..
For Tax %, as of Mar 2025, the value is 7.00%. The value appears to be improving (decreasing) as expected. It has decreased from 21.00% (Dec 2024) to 7.00%, marking a decrease of 14.00%.
For Net Profit, as of Mar 2025, the value is 169.00 Cr.. The value appears strong and on an upward trend. It has increased from 137.00 Cr. (Dec 2024) to 169.00 Cr., marking an increase of 32.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 23.34. The value appears strong and on an upward trend. It has increased from 18.95 (Dec 2024) to 23.34, marking an increase of 4.39.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:37 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	5,826	6,130	6,366	6,505	6,802	7,957	7,405	8,889	13,127	14,663	13,364	15,036
Expenses	5,137	5,395	5,561	5,630	5,921	6,969	6,324	7,085	10,956	12,913	11,976	13,365
Operating Profit	688	735	805	874	881	988	1,081	1,804	2,171	1,749	1,387	1,671
OPM %	12%	12%	13%	13%	13%	12%	15%	20%	17%	12%	10%	11%
Other Income	29	18	38	25	22	19	28	23	71	-21	-745	-30
Interest	233	187	176	187	197	218	225	229	322	473	536	698
Depreciation	267	279	286	318	352	381	403	456	537	599	655	695
Profit before tax	217	286	382	395	354	409	481	1,142	1,382	656	-549	248
Tax %	7%	11%	17%	11%	12%	23%	23%	26%	20%	27%	26%	43%
Net Profit	202	256	317	351	312	315	371	844	1,099	481	-691	142
EPS in Rs	27.92	35.28	43.46	48.26	43.00	43.46	51.21	116.73	152.09	66.57	-95.69	19.71
Dividend Payout %	9%	8%	7%	7%	5%	5%	4%	2%	2%	5%	-1%	15%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	26.73%	23.83%	10.73%	-11.11%	0.96%	17.78%	127.49%	30.21%	-56.23%	-243.66%	120.55%
Change in YoY Net Profit Growth (%)	0.00%	-2.90%	-13.10%	-21.84%	12.07%	16.82%	109.72%	-97.28%	-86.45%	-187.43%	364.21%

Uflex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	9%
5 Years:	15%
3 Years:	5%
TTM:	13%

Compounded Profit Growth
10 Years:	-1%
5 Years:	-9%
3 Years:	-41%
TTM:	-36%

Stock Price CAGR
10 Years:	17%
5 Years:	23%
3 Years:	3%
1 Year:	14%

Return on Equity
10 Years:	9%
5 Years:	10%
3 Years:	5%
Last Year:	3%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:09 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	72	72	72	72	72	72	72	72	72	72	72	72
Reserves	2,751	2,935	3,376	3,572	3,907	4,232	4,625	5,484	6,624	7,433	7,153	7,324
Borrowings	2,416	2,210	2,139	2,102	2,079	2,105	3,626	4,041	4,787	5,704	6,947	8,353
Other Liabilities	1,356	1,250	1,217	1,402	1,629	1,550	1,693	2,222	2,959	3,229	3,176	3,687
Total Liabilities	6,595	6,468	6,804	7,148	7,688	7,960	10,016	11,820	14,441	16,438	17,348	19,437
Fixed Assets	3,378	3,240	3,255	3,394	3,766	3,759	3,808	5,032	6,417	7,786	8,223	8,752
CWIP	74	32	229	498	196	261	2,007	1,518	671	466	538	712
Investments	126	138	111	76	85	42	199	205	212	191	170	145
Other Assets	3,017	3,058	3,210	3,180	3,641	3,898	4,003	5,065	7,141	7,994	8,416	9,828
Total Assets	6,595	6,468	6,804	7,148	7,688	7,960	10,016	11,820	14,441	16,438	17,348	19,437

Below is a detailed analysis of the balance sheet data for Uflex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 72.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 72.00 Cr..
For Reserves, as of Mar 2025, the value is 7,324.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,153.00 Cr. (Mar 2024) to 7,324.00 Cr., marking an increase of 171.00 Cr..
For Borrowings, as of Mar 2025, the value is 8,353.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 6,947.00 Cr. (Mar 2024) to 8,353.00 Cr., marking an increase of 1,406.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 3,687.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,176.00 Cr. (Mar 2024) to 3,687.00 Cr., marking an increase of 511.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 19,437.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17,348.00 Cr. (Mar 2024) to 19,437.00 Cr., marking an increase of 2,089.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 8,752.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,223.00 Cr. (Mar 2024) to 8,752.00 Cr., marking an increase of 529.00 Cr..
For CWIP, as of Mar 2025, the value is 712.00 Cr.. The value appears strong and on an upward trend. It has increased from 538.00 Cr. (Mar 2024) to 712.00 Cr., marking an increase of 174.00 Cr..
For Investments, as of Mar 2025, the value is 145.00 Cr.. The value appears to be declining and may need further review. It has decreased from 170.00 Cr. (Mar 2024) to 145.00 Cr., marking a decrease of 25.00 Cr..
For Other Assets, as of Mar 2025, the value is 9,828.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,416.00 Cr. (Mar 2024) to 9,828.00 Cr., marking an increase of 1,412.00 Cr..
For Total Assets, as of Mar 2025, the value is 19,437.00 Cr.. The value appears strong and on an upward trend. It has increased from 17,348.00 Cr. (Mar 2024) to 19,437.00 Cr., marking an increase of 2,089.00 Cr..

However, the Borrowings (8,353.00 Cr.) are higher than the Reserves (₹7,324.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	331	501	875	779	651	553	849	1,174	709	1,383	825	1,135
Cash from Investing Activity +	-143	-197	-437	-669	-427	-344	-2,062	-1,095	-952	-1,172	-1,619	-1,732
Cash from Financing Activity +	-143	-319	-242	-202	-205	-237	1,369	134	216	292	776	678
Net Cash Flow	45	-15	196	-92	19	-27	155	214	-28	503	-18	80

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	686.00	733.00	803.00	872.00	879.00	986.00	-2.00	-3.00	-2.00	-4.00	-5.00	-7.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	91	94	90	85	93	104	94	96	99	98	80	94
Inventory Days	53	60	63	64	70	72	63	73	89	86	91	84
Days Payable	81	86	72	80	98	108	79	90	104	92	85	90
Cash Conversion Cycle	62	69	80	68	64	68	78	79	83	92	87	88
Working Capital Days	51	59	71	64	64	74	72	77	94	98	91	107
ROCE %	10%	9%	9%	10%	10%	9%	10%	10%	15%	17%	10%	6%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	44.02%	44.02%	44.02%	44.58%	44.58%	44.58%	44.58%	44.58%	44.58%	44.58%	44.58%	44.58%
FIIs	6.20%	6.42%	6.66%	7.09%	8.69%	8.34%	7.26%	7.14%	6.51%	7.04%	7.47%	8.03%
DIIs	1.15%	1.08%	0.33%	0.18%	0.22%	0.25%	0.66%	0.66%	0.68%	0.69%	0.70%	0.72%
Public	48.64%	48.48%	49.00%	48.15%	46.54%	46.84%	47.50%	47.62%	48.25%	47.70%	47.26%	46.67%
No. of Shareholders	52,812	57,147	56,625	56,391	55,221	57,626	61,970	62,817	66,409	63,367	58,352	53,073

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Motilal Oswal Nifty Microcap 250 Index Fund	40,093	0.18	2.4	40,093	2025-04-22 15:56:52	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	19.71	-95.69	66.57	152.09	116.73
Diluted EPS (Rs.)	19.71	-95.69	66.57	152.09	116.73
Cash EPS (Rs.)	115.94	-3.17	150.56	226.63	179.94
Book Value[Excl.RevalReserv]/Share (Rs.)	1024.30	1000.53	1039.38	927.25	769.49
Book Value[Incl.RevalReserv]/Share (Rs.)	1024.30	1000.53	1039.38	927.25	769.49
Revenue From Operations / Share (Rs.)	2082.27	1850.62	2030.49	1817.87	1231.21
PBDIT / Share (Rs.)	251.88	211.36	261.17	315.74	253.01
PBIT / Share (Rs.)	155.65	120.59	178.22	241.35	189.90
PBT / Share (Rs.)	34.36	-74.24	91.88	191.42	158.17
Net Profit / Share (Rs.)	19.71	-93.94	67.61	152.25	116.83
NP After MI And SOA / Share (Rs.)	19.71	-95.69	66.57	152.09	116.73
PBDIT Margin (%)	12.09	11.42	12.86	17.36	20.54
PBIT Margin (%)	7.47	6.51	8.77	13.27	15.42
PBT Margin (%)	1.65	-4.01	4.52	10.53	12.84
Net Profit Margin (%)	0.94	-5.07	3.32	8.37	9.48
NP After MI And SOA Margin (%)	0.94	-5.17	3.27	8.36	9.48
Return on Networth / Equity (%)	1.92	-9.57	6.41	16.42	15.16
Return on Capital Employeed (%)	8.66	7.20	11.10	16.81	15.67
Return On Assets (%)	0.73	-3.98	2.92	7.60	7.12
Long Term Debt / Equity (X)	0.65	0.57	0.46	0.45	0.50
Total Debt / Equity (X)	1.10	0.93	0.73	0.68	0.64
Asset Turnover Ratio (%)	0.81	0.79	0.63	0.64	0.62
Current Ratio (X)	1.31	1.46	1.56	1.64	1.55
Quick Ratio (X)	0.91	1.09	1.08	1.19	1.18
Inventory Turnover Ratio (X)	4.22	3.88	3.36	4.03	3.85
Dividend Payout Ratio (NP) (%)	0.00	-3.13	4.50	1.64	1.71
Dividend Payout Ratio (CP) (%)	0.00	-60.99	2.00	1.10	1.11
Earning Retention Ratio (%)	0.00	103.13	95.50	98.36	98.29
Cash Earning Retention Ratio (%)	0.00	160.99	98.00	98.90	98.89
Interest Coverage Ratio (X)	2.61	2.85	3.98	7.07	7.98
Interest Coverage Ratio (Post Tax) (X)	1.46	1.36	2.35	4.53	4.68
Enterprise Value (Cr.)	10551.97	8579.76	6834.46	8380.47	5629.29
EV / Net Operating Revenue (X)	0.70	0.64	0.46	0.63	0.63
EV / EBITDA (X)	5.80	5.62	3.62	3.68	3.08
MarketCap / Net Operating Revenue (X)	0.23	0.21	0.16	0.33	0.30
Retention Ratios (%)	0.00	103.13	95.49	98.35	98.28
Price / BV (X)	0.48	0.40	0.32	0.65	0.49
Price / Net Operating Revenue (X)	0.23	0.21	0.16	0.33	0.30
EarningsYield	0.03	-0.23	0.19	0.24	0.30

After reviewing the key financial ratios for Uflex Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
For Diluted EPS (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
For Cash EPS (Rs.), as of Mar 25, the value is 115.94. This value is within the healthy range. It has increased from -3.17 (Mar 24) to 115.94, marking an increase of 119.11.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,024.30. It has increased from 1,000.53 (Mar 24) to 1,024.30, marking an increase of 23.77.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,024.30. It has increased from 1,000.53 (Mar 24) to 1,024.30, marking an increase of 23.77.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,082.27. It has increased from 1,850.62 (Mar 24) to 2,082.27, marking an increase of 231.65.
For PBDIT / Share (Rs.), as of Mar 25, the value is 251.88. This value is within the healthy range. It has increased from 211.36 (Mar 24) to 251.88, marking an increase of 40.52.
For PBIT / Share (Rs.), as of Mar 25, the value is 155.65. This value is within the healthy range. It has increased from 120.59 (Mar 24) to 155.65, marking an increase of 35.06.
For PBT / Share (Rs.), as of Mar 25, the value is 34.36. This value is within the healthy range. It has increased from -74.24 (Mar 24) to 34.36, marking an increase of 108.60.
For Net Profit / Share (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -93.94 (Mar 24) to 19.71, marking an increase of 113.65.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
For PBDIT Margin (%), as of Mar 25, the value is 12.09. This value is within the healthy range. It has increased from 11.42 (Mar 24) to 12.09, marking an increase of 0.67.
For PBIT Margin (%), as of Mar 25, the value is 7.47. This value is below the healthy minimum of 10. It has increased from 6.51 (Mar 24) to 7.47, marking an increase of 0.96.
For PBT Margin (%), as of Mar 25, the value is 1.65. This value is below the healthy minimum of 10. It has increased from -4.01 (Mar 24) to 1.65, marking an increase of 5.66.
For Net Profit Margin (%), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 5. It has increased from -5.07 (Mar 24) to 0.94, marking an increase of 6.01.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 8. It has increased from -5.17 (Mar 24) to 0.94, marking an increase of 6.11.
For Return on Networth / Equity (%), as of Mar 25, the value is 1.92. This value is below the healthy minimum of 15. It has increased from -9.57 (Mar 24) to 1.92, marking an increase of 11.49.
For Return on Capital Employeed (%), as of Mar 25, the value is 8.66. This value is below the healthy minimum of 10. It has increased from 7.20 (Mar 24) to 8.66, marking an increase of 1.46.
For Return On Assets (%), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has increased from -3.98 (Mar 24) to 0.73, marking an increase of 4.71.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.65. This value is within the healthy range. It has increased from 0.57 (Mar 24) to 0.65, marking an increase of 0.08.
For Total Debt / Equity (X), as of Mar 25, the value is 1.10. This value exceeds the healthy maximum of 1. It has increased from 0.93 (Mar 24) to 1.10, marking an increase of 0.17.
For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has increased from 0.79 (Mar 24) to 0.81, marking an increase of 0.02.
For Current Ratio (X), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.31, marking a decrease of 0.15.
For Quick Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.09 (Mar 24) to 0.91, marking a decrease of 0.18.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.22. This value is within the healthy range. It has increased from 3.88 (Mar 24) to 4.22, marking an increase of 0.34.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -3.13 (Mar 24) to 0.00, marking an increase of 3.13.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -60.99 (Mar 24) to 0.00, marking an increase of 60.99.
For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 103.13 (Mar 24) to 0.00, marking a decrease of 103.13.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 160.99 (Mar 24) to 0.00, marking a decrease of 160.99.
For Interest Coverage Ratio (X), as of Mar 25, the value is 2.61. This value is below the healthy minimum of 3. It has decreased from 2.85 (Mar 24) to 2.61, marking a decrease of 0.24.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 3. It has increased from 1.36 (Mar 24) to 1.46, marking an increase of 0.10.
For Enterprise Value (Cr.), as of Mar 25, the value is 10,551.97. It has increased from 8,579.76 (Mar 24) to 10,551.97, marking an increase of 1,972.21.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 1. It has increased from 0.64 (Mar 24) to 0.70, marking an increase of 0.06.
For EV / EBITDA (X), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 5.62 (Mar 24) to 5.80, marking an increase of 0.18.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 103.13 (Mar 24) to 0.00, marking a decrease of 103.13.
For Price / BV (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.40 (Mar 24) to 0.48, marking an increase of 0.08.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from -0.23 (Mar 24) to 0.03, marking an increase of 0.26.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Uflex Ltd as of June 22, 2025 is: 477.23

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 22, 2025, Uflex Ltd is Overvalued by 18.98% compared to the current share price 589.00

Intrinsic Value of Uflex Ltd as of June 22, 2025 is: 334.37

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 22, 2025, Uflex Ltd is Overvalued by 43.23% compared to the current share price 589.00

Last 5 Year EPS CAGR: -29.94%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (4,951.33 cr) compared to borrowings (3,875.75 cr), indicating strong financial stability. The company has shown consistent growth in sales (8.83 cr) and profit (240.08 cr) over the years.	The stock has a low average ROCE of 10.42%, which may not be favorable. The stock has a high average Working Capital Days of 76.83, which may not be favorable. The stock has a high average Cash Conversion Cycle of 76.50, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uflex Ltd:
1. Net Profit Margin: 0.94%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 8.66% (Industry Average ROCE: 12.34%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 1.92% (Industry Average ROE: 18.47%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 1.46
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.91
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 18.7 (Industry average Stock P/E: 58.42)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 1.1
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Uflex Ltd. is a Public Limited Listed company incorporated on 21/06/1988 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1988PLC032166 and registration number is 032166. Currently Company is involved in the business activities of Manufacture of other plastics products. Company's Total Operating Revenue is Rs. 7724.74 Cr. and Equity Capital is Rs. 72.21 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Packaging & Containers	305, Third Floor, Bhanot Corner, New Delhi Delhi 110048	secretarial@uflexltd.com http://www.uflexltd.com

Management
Name	Position Held
Mr. Ashok Chaturvedi	Chairman & Managing Director
Mr. Jeevaraj Gopal Pillai	Whole Time Director
Mrs. Sujit Kumar Varma	Independent Director
Mr. Ghyanendra Nath Bajpai	Independent Director
Mrs. Rashmi Verma	Independent Director
Mr. Paresh Nath Sharma	Independent Director

FAQ

What is the intrinsic value of Uflex Ltd?

Uflex Ltd's intrinsic value (as of 21 June 2025) is ₹477.23 — 18.98% lower the current market price of 589.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,251 Cr. market cap, FY2025-2026 high/low of ₹860/438, reserves of 7,324 Cr, and liabilities of 19,437 Cr.

What is the Market Cap of Uflex Ltd?

The Market Cap of Uflex Ltd is 4,251 Cr..

What is the current Stock Price of Uflex Ltd as on 21 June 2025?

The current stock price of Uflex Ltd as on 21 June 2025 is 589.

What is the High / Low of Uflex Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Uflex Ltd stocks is ₹860/438.

What is the Stock P/E of Uflex Ltd?

The Stock P/E of Uflex Ltd is 18.7.

What is the Book Value of Uflex Ltd?

The Book Value of Uflex Ltd is 1,024.

What is the Dividend Yield of Uflex Ltd?

The Dividend Yield of Uflex Ltd is 0.17 %.

What is the ROCE of Uflex Ltd?

The ROCE of Uflex Ltd is 7.51 %.

What is the ROE of Uflex Ltd?

The ROE of Uflex Ltd is 3.11 %.

What is the Face Value of Uflex Ltd?

The Face Value of Uflex Ltd is 10.0.